GMED Q1 Earnings & Revenues Miss, '25 EPS View Down, Stock Falls

Globus Medical, Inc. (GMED) reported first-quarter 2025 adjusted earnings per share (EPS) of 68 cents, which missed the Zacks Consensus Estimate by 8.1%. The figure increased 7.9% year over year. Net sales generated in the United States increased 0.2% year over year (same at CER) to $483.9 million, which missed our model's projection of $519.2 million. Across international markets, revenues decreased 7.7% (down 4.6% at CER) to $114.3 million, which also missed our model estimate of $124.6 million. GMED's Pr ...